EA202091062A1 - CARBOXYLCHITOSAN - Google Patents

CARBOXYLCHITOSAN

Info

Publication number
EA202091062A1
EA202091062A1 EA202091062A EA202091062A EA202091062A1 EA 202091062 A1 EA202091062 A1 EA 202091062A1 EA 202091062 A EA202091062 A EA 202091062A EA 202091062 A EA202091062 A EA 202091062A EA 202091062 A1 EA202091062 A1 EA 202091062A1
Authority
EA
Eurasian Patent Office
Prior art keywords
surgery
field
carboxylchitosan
carboxyalkylchitosan
rheumatology
Prior art date
Application number
EA202091062A
Other languages
Russian (ru)
Inventor
Микаель Шоссон
Пьер Дуэтт
Сандрин Эмилия Готье
Филип Ваесен
Утэ Шуман
Гильермо Рокасальбас
Original Assignee
Киомед Фарма
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61802047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA202091062(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Киомед Фарма filed Critical Киомед Фарма
Publication of EA202091062A1 publication Critical patent/EA202091062A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Abstract

Настоящее изобретение относится к карбоксиалкилхитозану, содержащим его композициям, способу его получения и различным его применениям, в частности, в области терапии, ревматологии, офтальмологии, эстетической медицины, пластической хирургии, хирургии внутренних органов, дерматологии или косметической области.The present invention relates to carboxyalkylchitosan, compositions containing it, a method for its preparation and its various uses, in particular in the field of therapy, rheumatology, ophthalmology, aesthetic medicine, plastic surgery, surgery of internal organs, dermatology or the cosmetic field.

EA202091062A 2017-11-28 2018-11-09 CARBOXYLCHITOSAN EA202091062A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1761323A FR3074044B1 (en) 2017-11-28 2017-11-28 CARBOXYALKYL CHITOSANE
PCT/EP2018/080767 WO2019105719A1 (en) 2017-11-28 2018-11-09 Carboxyalkyl chitosan

Publications (1)

Publication Number Publication Date
EA202091062A1 true EA202091062A1 (en) 2020-08-07

Family

ID=61802047

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091062A EA202091062A1 (en) 2017-11-28 2018-11-09 CARBOXYLCHITOSAN

Country Status (20)

Country Link
US (2) US11667727B2 (en)
EP (1) EP3510051B2 (en)
AR (1) AR115049A1 (en)
CA (1) CA3082557A1 (en)
CL (1) CL2020001323A1 (en)
DK (1) DK3510051T3 (en)
EA (1) EA202091062A1 (en)
ES (1) ES2781787T5 (en)
FI (1) FI3510051T4 (en)
FR (1) FR3074044B1 (en)
HR (1) HRP20200411T4 (en)
MA (1) MA49811A1 (en)
MX (1) MX2020005002A (en)
PE (1) PE20210441A1 (en)
PL (1) PL3510051T5 (en)
PT (1) PT3510051T (en)
SG (1) SG11202005039WA (en)
TN (1) TN2020000070A1 (en)
UA (1) UA126087C2 (en)
WO (1) WO2019105719A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112111022B (en) * 2020-10-10 2021-06-04 山东一滕新材料股份有限公司 Modified chitosan, preparation method thereof, ceramic tile glue additive and application thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619995A (en) * 1984-12-24 1986-10-28 Nova Chem Limited N,O-carboxymethyl chitosan and preparative method therefor
US5679658A (en) * 1995-05-08 1997-10-21 Chitogenics, Inc. N,O-carbonxymethylchitosan for prevention of surgical adhesions
DE19725037B4 (en) 1997-06-13 2004-08-05 Cognis Deutschland Gmbh & Co. Kg Chitin derivatives, process for their preparation and their use
US6645947B1 (en) * 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
BE1014638A6 (en) 2002-02-12 2004-02-03 Univ Liege Method of preparation of derivatives of cell wall from biomass.
CN1193044C (en) 2003-01-09 2005-03-16 武汉大学 Carboxymethyl chitosan, its preparing method and usage
US20070082851A1 (en) 2003-11-24 2007-04-12 Optimer Pharmaceuticals Inc. Treatment of a condition in a mammal with administration of Compounds and Methods of Use
BE1016383A3 (en) 2004-12-15 2006-10-03 Physiol Polymer composition for intraocular lens.
CN102688195B (en) 2012-06-06 2014-01-08 中国海洋大学 Preparation method for doxorubicin hydrochloride-entrapped chitosan carboxymethyl chitosan nanometer controlled-release particle with pH sensibility
CN103937014B (en) 2014-04-10 2016-05-25 北京爱美客生物科技有限公司 Shitosan dual network rapid response type injection aquagel and preparation method thereof
FR3024363B1 (en) * 2014-08-01 2018-08-10 Synolyne Pharma THERMOGELIFIABLE COMPOSITION
FR3024362A1 (en) 2014-08-01 2016-02-05 Synolyne Pharma Sa STERILIZED THERMOGELIFIABLE COMPOSITION
FR3029116B1 (en) 2014-12-01 2018-03-30 Advanced Chitosan Solutions Biotech PROCESS FOR OBTAINING A CARTILAGE GEL FOR CARTILAGE REPAIR COMPRISING CHITOSAN AND CHONDROCYTES
FR3038837B1 (en) 2015-07-13 2017-08-18 Synolyne Pharma CHITOSANE FOR MIXING WITH A COAGULABLE FLUID
FR3038838B1 (en) 2015-07-13 2017-08-18 Synolyne Pharma CHITOSANE FOR MIXING WITH A COAGULABLE FLUID
CN106474569B (en) 2016-12-02 2019-04-09 上海其胜生物制剂有限公司 A kind of preparation method of the critical hydrogel of carboxymethyl chitin
CN107325306B (en) 2017-06-13 2019-10-25 爱美客技术发展股份有限公司 The multiple cross-linked gel of chitosan or derivatives thereof and preparation method
FR3116534B1 (en) 2020-11-23 2023-12-22 Kiomed Pharma Chitosan-based beads, preparation, compositions and applications

Also Published As

Publication number Publication date
MX2020005002A (en) 2020-08-27
EP3510051B2 (en) 2022-10-05
FR3074044A1 (en) 2019-05-31
PE20210441A1 (en) 2021-03-08
SG11202005039WA (en) 2020-06-29
CL2020001323A1 (en) 2020-09-11
MA49811A1 (en) 2020-10-28
PL3510051T5 (en) 2023-01-30
UA126087C2 (en) 2022-08-10
CA3082557A1 (en) 2019-06-06
DK3510051T3 (en) 2020-03-16
TN2020000070A1 (en) 2022-01-06
US11667727B2 (en) 2023-06-06
PT3510051T (en) 2020-04-06
US20230174682A1 (en) 2023-06-08
EP3510051A1 (en) 2019-07-17
HRP20200411T1 (en) 2020-06-12
FI3510051T4 (en) 2022-12-15
PL3510051T3 (en) 2020-11-02
ES2781787T5 (en) 2023-02-27
HRP20200411T4 (en) 2022-11-25
WO2019105719A1 (en) 2019-06-06
FR3074044B1 (en) 2019-11-01
US20210171667A1 (en) 2021-06-10
EP3510051B1 (en) 2020-01-01
ES2781787T3 (en) 2020-09-07
AR115049A1 (en) 2020-11-25

Similar Documents

Publication Publication Date Title
WO2014176128A3 (en) Compositions and methods for the therapy and diagnosis of influenza
EA201290836A1 (en) RELATED BIS-ARYL ARYLTRIAZOLONES AND THEIR APPLICATION
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
CY1125179T1 (en) PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
CY1123366T1 (en) 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
CY1122892T1 (en) 3-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
CY1120642T1 (en) PHARMACEUTICAL COMPOSITION OF IBUPROFEMEN AND TRAMADOL FOR OPHTHALMOLOGICAL USE
CY1122882T1 (en) 3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
EA201790223A1 (en) WATER PREPARATION CONTAINING PARACETAMOL AND IBUPROFEN
EA202190281A1 (en) DERIVATIVES 3 - ((HETERO-) ARYL) -8-AMINO-2-OXO-1,3-DIAZA-SPIRO [4,5] DECANE
BR112012015386B8 (en) topical ophthalmic composition
PH12019501999A1 (en) Pyrazole derivatives as bromodomain inhibitors
EA201792085A1 (en) MIXED DISULPHIDE CONJUGATES OF THYENOPYRIDINE COMPOUNDS AND THEIR APPLICATION
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
CY1116158T1 (en) Substituted 2-oxo- and 2-thiooxy-dihydroquinoline-3-carboxamides as KCNQ2 / 3 modulators
TR201905218T4 (en) USEFUL VITANOLIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
EA202091062A1 (en) CARBOXYLCHITOSAN
EA202092045A1 (en) TREATMENT AND PREVENTION OF PREECLAMPSIA
BR112019017314A2 (en) pharmaceutical compositions for combination therapy
CY1124077T1 (en) XITOZANH ANIONTIKOY OF CARGO
EA201501130A1 (en) OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION
EA201700074A1 (en) STABLE NON-CONTAINERS OPHTHALMIC COMPOSITIONS OF OPIOID ANTAGONISTS
EA201790020A1 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASES